Literature DB >> 22537985

Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model.

Hetron M Munang'andu1, Børge N Fredriksen, Stephen Mutoloki, Bjørn Brudeseth, Tsun-Yung Kuo, Inderjit S Marjara, Roy A Dalmo, Øystein Evensen.   

Abstract

Two strains of IPNV made by reverse genetics on the Norwegian Sp strain NVI-015 (GenBank AY379740) backbone encoding the virulent (T(217)A(221)) and avirulent (P(217)T(221)) motifs were used to prepare inactivated whole virus (IWV), nanoparticle vaccines with whole virus, Escherichia coli subunit encoding truncated VP2-TA and VP2-PT, VP2-TA and VP2-PT fusion antigens with putative translocating domains of Pseudomonas aeruginosa exotoxin, and plasmid DNA encoding segment A of the TA strain. Post challenge survival percentages (PCSP) showed that IWV vaccines conferred highest protection (PCSP=42-53) while nanoparticle, sub-unit recombinant and DNA vaccines fell short of the IWV vaccines in Atlantic salmon (Salmo salar L.) postsmolts challenged with the highly virulent Sp strain NVI-015 (TA strain) of IPNV after 560 degree days post vaccination. Antibody levels induced by these vaccines did not show antigenic differences between the virulent and avirulent motifs for vaccines made with the same antigen dose and delivery system after 8 weeks post vaccination. Our findings show that fish vaccinated with less potent vaccines comprising of nanoparticle, DNA and recombinant vaccines got infected much earlier and yielded to higher infection rates than fish vaccinated with IWV vaccines that were highly potent. Ability of the virulent (T(217)A(221)) and avirulent (P(217)T(221)) motifs to limit establishment of infection showed equal protection for vaccines made of the same antigen dose and delivery systems. Prevention of tissue damage linked to viral infection was eminent in the more potent vaccines than the less protective ones. Hence, there still remains the challenge of developing highly efficacious vaccines with the ability to eliminate the post challenge carrier state in IPNV vaccinology.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537985     DOI: 10.1016/j.vaccine.2012.04.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Fundamentals of Fish Vaccination.

Authors:  Megha Kadam Bedekar; Sajal Kole
Journal:  Methods Mol Biol       Date:  2022

Review 2.  A Review of Intra- and Extracellular Antigen Delivery Systems for Virus Vaccines of Finfish.

Authors:  Hetron Mweemba Munang'andu; Øystein Evensen
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

3.  IPNV Antigen Uptake and Distribution in Atlantic Salmon Following Oral Administration.

Authors:  Lihan Chen; Øystein Evensen; Stephen Mutoloki
Journal:  Viruses       Date:  2015-05-21       Impact factor: 5.048

Review 4.  Strategies and hurdles using DNA vaccines to fish.

Authors:  Linn B Hølvold; Anne I Myhr; Roy A Dalmo
Journal:  Vet Res       Date:  2014-02-19       Impact factor: 3.683

5.  Augmentation of the antibody response of Atlantic salmon by oral administration of alginate-encapsulated IPNV antigens.

Authors:  Lihan Chen; Goran Klaric; Simon Wadsworth; Suwan Jayasinghe; Tsun-Yung Kuo; Øystein Evensen; Stephen Mutoloki
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

6.  A polyprotein-expressing salmonid alphavirus replicon induces modest protection in atlantic salmon (Salmo salar) against infectious pancreatic necrosis.

Authors:  Azila Abdullah; Christel M Olsen; Kjartan Hodneland; Espen Rimstad
Journal:  Viruses       Date:  2015-01-19       Impact factor: 5.048

Review 7.  Challenges and Solutions to Viral Diseases of Finfish in Marine Aquaculture.

Authors:  Kizito K Mugimba; Denis K Byarugaba; Stephen Mutoloki; Øystein Evensen; Hetron M Munang'andu
Journal:  Pathogens       Date:  2021-05-30

8.  Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L).

Authors:  Hetron Mweemba Munang'andu; Børge Nilsen Fredriksen; Stephen Mutoloki; Roy Ambli Dalmo; Øystein Evensen
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

9.  Immunogenicity and cross protective ability of the central VP2 amino acids of infectious pancreatic necrosis virus in Atlantic salmon (Salmo salar L.).

Authors:  Hetron M Munang'andu; Ane Sandtrø; Stephen Mutoloki; Bjørn E Brudeseth; Nina Santi; Øystein Evensen
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

10.  Aeromonas hydrophila OmpW PLGA Nanoparticle Oral Vaccine Shows a Dose-Dependent Protective Immunity in Rohu (Labeo rohita).

Authors:  Saurabh Dubey; Kiran Avadhani; Srinivas Mutalik; Sangeetha Madambithara Sivadasan; Biswajit Maiti; Joydeb Paul; Shivani Kallappa Girisha; Moleyur Nagarajappa Venugopal; Stephen Mutoloki; Øystein Evensen; Indrani Karunasagar; Hetron Mweemba Munang'andu
Journal:  Vaccines (Basel)       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.